Nigeria’s health system is increasingly shaped by a quiet but consequential distortion: the routine overdiagnosis of typhoid fever. What appears, at first glance, as a clinical convenience is, in fact, a governance failure embedded in diagnostics, regulation, and surveillance.
In many settings, febrile illness is swiftly labelled as typhoid, often based on poorly specific tests and weak clinical confirmation pathways. This practice is reinforced by patient expectations, cost pressures, uneven laboratory capacity, and inconsistent regulatory enforcement.
The result is not merely a diagnostic error. It is systemic distortion: inflated disease reporting, unnecessary antibiotic use, and accelerating antimicrobial resistance (AMR). Nigeria’s surveillance architecture is consequently weakened, producing data that reflects clinical convention more than epidemiological reality.
This policy brief argues that the problem is not primarily technical but institutional. Diagnostic accuracy fails because governance systems do not consistently reward precision or penalise deviation.
It proposes four reform pathways:
1. Strengthening diagnostic standards and validation
2. Aligning incentives with accuracy through financing and regulation
3. Improving surveillance integrity through verification systems
4. Rebuilding public trust through communication and professional accountability
Without such reforms, diagnostic shortcuts will remain rational, and the system will continue to reproduce error at scale.
The Institutional Nature of Diagnostic Failure
Nigeria’s health system cannot claim credibility while diagnostic shortcuts remain routine. Few issues expose this more starkly than the widespread overdiagnosis of typhoid fever. Across many facilities, any febrile presentation is routinely labelled as typhoid, a practice sustained by unvalidated tests and permissive regulatory oversight. What presents as a clinical challenge is, in fact, an institutional failure: a system that privileges speed over accuracy, volume over verification, and discretion over enforceable standards.
False typhoid diagnoses persist not because the science is uncertain, but because the governance framework does not enforce accuracy. Confirmatory diagnostics exist, yet their use remains constrained by cost, infrastructure deficits, and uneven implementation. More importantly, national standards, while formally established, are weakly enforced in practice. Federal guidelines depend on state structures and professional bodies for compliance, but supervision is inconsistent, particularly within private laboratories where inspections are infrequent, and sanctions are rarely applied.
These weaknesses generate predictable incentives. Providers face minimal consequence for poor diagnostic quality; patients, in turn, demand rapid treatment; and shortcuts reduce both time and cost pressures. The result is a persistent divergence between formal policy and everyday practice, one that distorts disease surveillance, accelerates unnecessary antibiotic use, and undermines antimicrobial stewardship.
Typhoid is widely diagnosed, yet much of the recorded burden reflects diagnostic uncertainty rather than confirmed infection. Continued reliance on the Widal test, alongside limited access to confirmatory diagnostics, produces ambiguous clinical signals that frequently translate into empirical antibiotic prescribing. Under pressure from time constraints, patient expectations, and weak oversight, discretion supplants diagnostic rigour. Typhoid fever
Within this environment, antibiotic misuse becomes entrenched. Regulatory bodies issue guidelines, but enforcement remains uneven. Over-the-counter antibiotic sales persist despite formal restrictions, while surveys indicate widespread self-medication. The consequence is a substantial antimicrobial resistance burden, including over 263,000 deaths linked to resistant infections, reflecting a systemic governance failure rather than isolated clinical misconduct.
This is an institutional chain with cumulative effects: diagnostic ambiguity enables discretionary prescribing; weak enforcement normalises substandard practice; and sustained antibiotic misuse accelerates resistance. The central constraint is not technical capacity, but governance discipline.
What the Evidence Reveals
Evidence from across Nigeria is consistent and unambiguous: false typhoid diagnoses are widespread, and prevailing diagnostic practices significantly inflate the apparent burden of disease. Studies repeatedly demonstrate that the Widal test, still widely used in both public and private facilities, yields high false-positive rates, particularly in endemic settings where baseline antibody levels are elevated. By contrast, where blood culture is employed, confirmed typhoid incidence is substantially lower than routine clinical reporting indicates. Typhoid fever
Household and facility-level surveys show extensive empirical antibiotic use in response to fever. A majority of Nigerians access antibiotics without a prescription, frequently based on informal assessments of malaria or typhoid. This pattern is reinforced by weak enforcement of prescription-only regulations and by retail environments in which antibiotics remain readily accessible. Antimicrobial resistance
The antimicrobial resistance data further reinforce these findings. Nigeria records one of the highest burdens of AMR-related mortality globally. Surveillance evidence links rising resistance patterns to the extensive use of broad-spectrum antibiotics, commonly prescribed for presumed typhoid infections. Inflated typhoid figures, in turn, distort surveillance systems, weakening the ability to accurately characterise disease patterns or to design effective policy responses.
Where confirmatory diagnostics are consistently enforced, false-positive rates decline markedly. Comparative evidence from across Africa indicates that improved validation, strengthened supervision, and robust quality assurance—rather than new technological inputs alone—are associated with more accurate diagnosis.
Three conclusions emerge with clarity:
● Widal-based diagnosis substantially inflates estimated typhoid incidence.
● Empirical antibiotic treatment is widespread and weakly regulated.
● Weak diagnostic governance undermines both surveillance integrity and antimicrobial stewardship.
Taken together, the evidence points decisively to an institutional failure of governance, rather than a gap in scientific knowledge or technical capacity.
Why the System Sustains the Failure
False typhoid diagnoses persist because the system renders them rational. Providers operate under sustained pressure to deliver rapid consultations, minimise costs, and meet patient expectations. In high-volume clinical environments, unvalidated tests are inexpensive, quick to administer, and seldom subjected to scrutiny. By contrast, confirmatory diagnostics, while more accurate, are costlier, slower, and rarely mandated for reimbursement or regulatory compliance. Typhoid fever
Patients further reinforce this dynamic. High levels of out-of-pocket expenditure, combined with limited trust in protracted diagnostic pathways, encourage demand for immediate treatment. Typhoid has become a default explanatory label for persistent fever, and antibiotics are frequently expected as first-line care rather than as a consequence of confirmed diagnosis. Antimicrobial resistance
Private laboratories and pharmacies operate within uneven supervisory regimes. The costs of compliance—upgrading equipment, enforcing prescription-only protocols, and meeting diagnostic standards—are borne by individual providers, while the benefits of improved public health accrue system-wide. In the absence of consistent inspection and credible sanctions, voluntary compliance remains structurally weak.
Regulatory authorities themselves operate under both operational and political constraints. Enforcement capacity varies across states, inspection systems are limited, and stringent sanctions risk public backlash, particularly in settings where access to alternatives is constrained. The result is an implicit tolerance of practices that erode diagnostic accuracy.
These interacting pressures produce a stable but damaging equilibrium. Diagnostic shortcuts are individually rational for providers, patients, and private actors alike, while regulators face structural difficulty in shifting behaviour. Any meaningful reform must therefore begin by altering the incentive structures that sustain this equilibrium.
Comparative Insights
Across Africa, several countries have addressed diagnostic inaccuracy not through technological expansion, but through deliberate redesign of the governance architecture that shapes diagnostic behaviour. Their experience demonstrates that Nigeria’s challenge is not intractable; however, it is fundamentally institutional in nature and cannot be resolved through technical substitution alone.
Ghana strengthened diagnostic governance by linking laboratory operations to a national external quality assurance framework. Facilities that repeatedly failed verification lost accreditation, while reimbursement under insurance schemes was made conditional on validated testing. This enforcement mechanism aligned incentives across both public and private providers and significantly reduced reliance on non-standard rapid tests. The central lesson is straightforward: diagnostic accuracy improved when compliance became economically rational.
Kenya adopted a more explicitly regulatory approach. The Pharmacy and Poisons Board, in coordination with the National Public Health Laboratory, introduced routine supervisory audits backed by enforceable sanctions for non-compliance. Crucially, Kenya also distinguished between “clinical suspicion” and “confirmed cases” within its surveillance system, thereby removing incentives for facilities to report unverified diagnoses. The governance insight is clear: surveillance integrity improves when reporting systems reward verification rather than volume. Kenya
South Africa embedded diagnostic governance within its financing architecture. Through the National Health Laboratory Service, diagnostic standards are centrally regulated, and reimbursement under public insurance is strictly contingent on adherence to approved testing protocols. Laboratories are not remunerated for tests conducted outside established algorithms. This has fostered a system in which diagnostic accuracy is not discretionary, but structurally required. South Africa
Across these three cases, the lesson is consistent: reform succeeded not because clinical behaviour changed voluntarily, but because institutional design altered the cost structure of inaccuracy.
For Nigeria, the implication is direct. In the absence of credible enforcement mechanisms, financial penalties for non-standard testing, and surveillance systems that prioritise verified diagnosis, diagnostic shortcuts will remain both rational and widespread. Comparative experience indicates that progress depends less on exhortation than on governance discipline: reward accuracy, penalise deviation, and embed standards within the core systems of financing and reporting.
Policy Pathways for Reform
Nigeria can reverse the entrenched cycle of diagnostic inaccuracy only by reshaping the governance environment that currently rewards diagnostic shortcuts. The following four pathways set out institution-anchored reforms designed to ensure that accuracy becomes the default rather than the exception.
A. Restore Diagnostic Credibility
1. Mandate validated testing protocols across all facilities
Nigeria must formally prohibit the routine use of unvalidated Widal tests and require strict adherence to nationally approved diagnostic algorithms. The Medical Laboratory Science Council of Nigeria (MLSCN) should publish a restricted and authoritative list of approved typhoid diagnostics and ensure uniform enforcement across both public and private facilities. Typhoid fever
2. Introduce facility-level diagnostic accountability
Hospitals and laboratories should be required to record, audit, and publicly report diagnostic accuracy metrics. Facilities demonstrating persistent underperformance should face graduated administrative sanctions, including suspension of diagnostic privileges.
Responsible institutions: MLSCN, Federal Ministry of Health (FMoH), NCDC
B. Align Incentives and Enforcement
1. Link compliance to reimbursement and licensing
National Health Insurance Authority (NHIA) reimbursements, as well as private insurance payouts, should be explicitly contingent on the use of validated diagnostic protocols. Facilities deploying non-approved tests should be rendered ineligible for reimbursement and subject to regulatory penalties.
2. Enforce targeted regulatory consequences
The MLSCN and state ministries of health should implement periodic, unannounced compliance inspections backed by enforceable sanctions. These should include fines, licence suspension, and withdrawal from eligibility for public procurement in cases of repeated non-compliance.
Responsible institutions: NHIA, MLSCN, State Health Ministries
C. Strengthen Surveillance Integrity
1. Distinguish clinically suspected from laboratory-confirmed cases
National surveillance systems must clearly separate suspected clinical diagnoses from laboratory-confirmed cases. This distinction is essential to reduce reporting inflation, improve data reliability, and align Nigeria with established international epidemiological standards.
2. Embed verification checkpoints into disease reporting
The Nigeria Centre for Disease Control (NCDC) should introduce automated validation mechanisms within reporting platforms, flagging facilities with significant discrepancies between suspected and confirmed cases. Facilities exceeding defined thresholds should be subject to structured supervisory review. Nigeria Centre for Disease Control
Responsible institutions: NCDC, DHIS2/NHIS reporting units, State Epidemiology Units
D. Rebuild Public Trust
1. Launch a national communication campaign on febrile illnesses
Public understanding must be recalibrated: not all fevers are typhoid. A coordinated national communication strategy—leveraging radio, community health workers, and digital platforms—should directly confront entrenched misconceptions that drive demand for inaccurate testing.
2. Strengthen professional accountability
Professional regulatory bodies should establish clear disciplinary mechanisms for clinicians and laboratories that repeatedly issue false or unsupported diagnoses. Restoring confidence in the system requires visible consequences for systemic malpractice.
Responsible institutions: FMoH, NCDC, MLSCN, MDCN, Health Promotion Units.
Across all four pathways, the underlying principle is consistent: diagnostic accuracy must be structurally enforced, not rhetorically encouraged. Only when governance mechanisms make deviation costly and compliance rational will Nigeria begin to dismantle the institutional conditions sustaining false typhoid diagnosis.
Strategic Logic Behind These Pathways
These reforms are unified by a single governing principle: diagnostic accuracy improves only when institutions reshape the incentives that structure clinical behaviour.
The pathways, therefore, represent a shift in Nigeria’s health governance architecture—from nominal rules to enforceable standards; from voluntary compliance to compliance anchored in incentives and sanctions; from inflated and unreliable surveillance data to verified national health intelligence; and from entrenched public scepticism to restored institutional trust.
Taken together, these shifts are not incremental adjustments but structural corrections to the incentive environment in which diagnosis currently occurs. They reconstitute the relationship between regulation, financing, and clinical practice in ways that make accuracy both economically rational and institutionally required.
This, ultimately, is the governance architecture required for a credible and functioning health system.
Conclusion: The Institutional Stakes
Nigeria cannot build a credible health system while diagnostic inaccuracy remains tolerated. False typhoid diagnoses are not a marginal technical inconvenience; they reveal deeper weaknesses in how standards are defined, enforced, and sustained. When diagnostic accuracy becomes discretionary rather than obligatory, the integrity of the entire health intelligence system is compromised. Typhoid fever
This challenge extends beyond a single disease. It is, at its core, a test of whether Nigeria can enforce national standards, align incentives with diagnostic accuracy, and shield its population from the escalating consequences of antimicrobial resistance. Comparative experience demonstrates that progress is achieved not through incremental improvements in tools, but through the strengthening of institutions and the consistent application of governance discipline. Antimicrobial resistance
Restoring diagnostic credibility is therefore central to rebuilding trust across the health system—among patients, clinicians, regulators, and development partners alike. In the absence of institutional reform, the system will continue to generate unreliable data, sustain misaligned incentives, and expose the population to avoidable risk. With reform, however, Nigeria can re-anchor its health system on accuracy, accountability, and enforceable standards that command public confidence.